Sai Parenteral's

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
482.55
-2.65 (-0.55%)
BSENSE

Apr 28

BSE+NSE Vol: 1.84 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024

Compare Profit and Loss Results of Sai Parenteral's
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
124.00
1,859.00
-1,735.00
-93.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
124.00
1,859.00
-1,735.00
-93.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-45.00
45.00
100.00%
Raw Materials Consumed
73.00
882.00
-809.00
-91.72%
Power & Fuel Cost
2.00
168.00
-166.00
-98.81%
Employee Cost
10.00
242.00
-232.00
-95.87%
Operating Expenses
1.00
141.00
-140.00
-99.29%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
44.00
-43.00
-97.73%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
26.00
-22.00
-84.62%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
97.00
1,531.00
-1,434.00
-93.66%
Operating Profit (PBDIT) excl Other Income
26.00
328.00
-302.00
-92.07%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
27.00
333.00
-306.00
-91.89%
Interest
7.00
75.00
-68.00
-90.67%
Profit before Depriciation and Tax
19.00
258.00
-239.00
-92.64%
Depreciation
5.00
134.00
-129.00
-96.27%
Profit Before Taxation & Exceptional Items
14.00
123.00
-109.00
-88.62%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
123.00
-109.00
-88.62%
Provision for Tax
4.00
33.00
-29.00
-87.88%
Profit After Tax
10.00
90.00
-80.00
-88.89%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
924.00
-904.00
-97.84%
Profit Available for appropriations
30.00
1,014.00
-984.00
-97.04%
Appropriations
30.00
1,014.00
-984.00
-97.04%
Equity Dividend (%)
0%
40%
-40.00
Earnings Per Share
3.89
7.37
-3.48
-47.22%
Profit And Loss - Net Sales
Net Sales 124.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

Profit And Loss - Interest
Interest 7.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024